Provided by Tiger Fintech (Singapore) Pte. Ltd.

CMS

7.960
-0.070-0.87%
Volume:7.27M
Turnover:57.84M
Market Cap:19.42B
PE:7.58
High:8.140
Open:8.020
Low:7.860
Close:8.030
Loading ...

China Medical System (867.HK) Is Included in the S&P Global Sustainability Yearbook 2025

THOMSON REUTERS
·
14 Feb

China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership

Simply Wall St.
·
04 Feb

BRIEF-China Medical System Announces Agreement For Antibody Injection

Reuters
·
24 Jan

China Medical System(00867)Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα Monoclonal Antibody MG-K10

GlobeNewswire
·
24 Jan

China Medical System - Agreement for Class 1 Innovative Drug Mg-K10 Humanized Monoclonal Antibody Injection

THOMSON REUTERS
·
24 Jan

China Medical System Signs License Deal with Alpha Cognition for Alzheimer's Drug

MT Newswires Live
·
09 Jan

BRIEF-China Medical System Announces License, Collaboration And Distribution Agreement For Zunveyl

Reuters
·
08 Jan

China Medical System (00867)Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type

GlobeNewswire
·
08 Jan

China Medical System - Under Deal, Group to Have Exclusive Right to Develop, Others, Product in Asia (Excluding Japan), Australia and New Zealand

THOMSON REUTERS
·
08 Jan

China Medical System - Agreement for Improved New Drug Zunveyl for Treatment of Mild-to-Moderate Dementia of Alzheimer's Type

THOMSON REUTERS
·
08 Jan

China Medical System - License, Collaboration and Distribution Agreement With Alpha Cognition

THOMSON REUTERS
·
08 Jan

Investors Continue Waiting On Sidelines For China Medical System Holdings Limited (HKG:867)

Simply Wall St.
·
07 Jan

Declining Stock and Decent Financials: Is The Market Wrong About China Medical System Holdings Limited (HKG:867)?

Simply Wall St.
·
17 Dec 2024

China Medical System Gets Commercialization Rights for Anti-Gout Drug

MT Newswires Live
·
03 Dec 2024

BRIEF-China Medical System Says Unit Entered Into Exclusive Commercialization Agreement

Reuters
·
02 Dec 2024

China Medical System - Deal for Commercialization of Class 1 Innovative Drug Abp-671 for Treatment of Gout & Hyperuricemia

THOMSON REUTERS
·
02 Dec 2024